Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial (Q36632019)

From Wikidata

Jump to navigation Jump to search

scientific article published on 27 June 2011

Language	Label	Description	Also known as
English	Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial	scientific article published on 27 June 2011

Statements

scholarly article

1 reference

Europe PubMed Central

15 August 2017

Antigen-based therapy with glutamic acid decarboxylase (GAD) vaccine in patients with recent-onset type 1 diabetes: a randomised double-blind trial (English)

1 reference

Europe PubMed Central

15 August 2017

type-1 diabetes

0 references

1 reference

based on heuristic

inferred from title

6

object named as

Robin Goland

1 reference

Europe PubMed Central

15 August 2017

Linda A. DiMeglio

4

object named as

Linda A DiMeglio

1 reference

Europe PubMed Central

15 August 2017

17

object named as

Desmond Schatz

1 reference

Europe PubMed Central

15 August 2017

Jeffrey P Krischer

19

object named as

Jeffrey P Krischer

1 reference

Europe PubMed Central

15 August 2017

9

object named as

Kevan C Herold

1 reference

Europe PubMed Central

15 August 2017

Carla J Greenbaum

8

object named as

Carla J Greenbaum

1 reference

Europe PubMed Central

15 August 2017

Darrell M. Wilson

18

object named as

Darrell M Wilson

1 reference

Europe PubMed Central

15 August 2017

20

object named as

Jay S Skyler

1 reference

Europe PubMed Central

15 August 2017

Dorothy J Becker

3

object named as

Dorothy J Becker

1 reference

Europe PubMed Central

15 August 2017

Jerry P. Palmer

14

object named as

Jerry P Palmer

1 reference

Europe PubMed Central

15 August 2017

author name string

Diane K Wherrett

1

1 reference

Europe PubMed Central

15 August 2017

Brian Bundy

2

1 reference

Europe PubMed Central

15 August 2017

Stephen E Gitelman

5

1 reference

Europe PubMed Central

15 August 2017

Peter A Gottlieb

7

1 reference

Europe PubMed Central

15 August 2017

Jennifer B Marks

10

1 reference

Europe PubMed Central

15 August 2017

Roshanak Monzavi

11

1 reference

Europe PubMed Central

15 August 2017

Antoinette Moran

12

1 reference

Europe PubMed Central

15 August 2017

Tihamer Orban

13

1 reference

Europe PubMed Central

15 August 2017

Philip Raskin

15

1 reference

Europe PubMed Central

15 August 2017

Henry Rodriguez

16

1 reference

Europe PubMed Central

15 August 2017

Type 1 Diabetes TrialNet GAD Study Group

21

1 reference

Europe PubMed Central

15 August 2017

language of work or name

0 references

publication date

27 June 2011

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

378

1 reference

Europe PubMed Central

15 August 2017

319-327

1 reference

Europe PubMed Central

15 August 2017

9788

1 reference

Europe PubMed Central

15 August 2017

Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

Stopping type 1 diabetes: attempts to prevent or cure type 1 diabetes in man.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

Standards of medical care in diabetes--2011.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

Antigen-specific immunotherapy for type 1 diabetes: maximizing the potential

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

Immunotherapy of type 1 diabetes: where are we and where should we be going?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

Prediction and pathogenesis in type 1 diabetes.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

Failure to preserve beta-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new- onset type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

Update on worldwide efforts to prevent type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

GAD treatment and insulin secretion in recent-onset type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

Mixed-meal tolerance test versus glucagon stimulation test for the assessment of beta-cell function in therapeutic trials in type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

Modulating the natural history of type 1 diabetes in children at high genetic risk by mucosal insulin immunization

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

Antigen-specific immunotherapy for autoimmune diseases

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

Type 1 diabetes: new perspectives on disease pathogenesis and treatment

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

Autoantibodies to GABA-ergic neurons and pancreatic beta cells in stiff-man syndrome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

Identification of the 64K autoantigen in insulin-dependent diabetes as the GABA-synthesizing enzyme glutamic acid decarboxylase

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

30 September 2017

No effect of oral insulin on residual beta-cell function in recent-onset type I diabetes (the IMDIAB VII). IMDIAB Group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

28 June 2018

Oral insulin administration and residual beta-cell function in recent-onset type 1 diabetes: a multicentre randomised controlled trial. Diabète Insuline Orale group.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

28 June 2018

Modulating autoimmune responses to GAD inhibits disease progression and prolongs islet graft survival in diabetes-prone mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

28 June 2018

Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

28 June 2018

Clinical evidence for the safety of GAD65 immunomodulation in adult-onset autoimmune diabetes

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

20 September 2018

Effects of oral insulin in relatives of patients with type 1 diabetes: The Diabetes Prevention Trial--Type 1.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

20 September 2018

C-peptide is the appropriate outcome measure for type 1 diabetes clinical trials to preserve beta-cell function: report of an ADA workshop, 21-22 October 2001.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

20 September 2018

Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

20 September 2018

Control of rheumatoid arthritis by oral tolerance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

20 September 2018

Induction of GAD65-specific regulatory T-cells inhibits ongoing autoimmune diabetes in nonobese diabetic mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

20 September 2018

Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3580128

4 December 2018

Effect of intensive therapy on residual beta-cell function in patients with type 1 diabetes in the diabetes control and complications trial. A randomized, controlled trial. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960895-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960895-7

7 January 2021

based on heuristic

inferred from DOI database lookup

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960895-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Developing combination immunotherapies for type 1 diabetes: recommendations from the ITN-JDRF Type 1 Diabetes Combination Therapy Assessment Group

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2811%2960895-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion. The Canadian-European Randomized Control Trial Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/21714999

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1016/S0140-6736(11)60895-7

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

1 reference

Europe PubMed Central

15 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q36632019&oldid=2050918279"